BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23307871)

  • 1. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.
    Kobayashi K; Tsubosaka Y; Hori M; Narumiya S; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):565-71. PubMed ID: 23307871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.
    Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG
    Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation.
    Li AQ; Zhao L; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C164-75. PubMed ID: 25377089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation.
    Kobayashi K; Sato K; Kida T; Omori K; Hori M; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1716-22. PubMed ID: 24925969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to prevent endothelial hyperpermeability: the Crataegus extract WS® 1442 targets the cAMP/Rap1 pathway.
    Bubik MF; Willer EA; Bihari P; Jürgenliemk G; Ammer H; Krombach F; Zahler S; Vollmar AM; Fürst R
    J Mol Cell Cardiol; 2012 Jan; 52(1):196-205. PubMed ID: 22085704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement.
    Umapathy NS; Zemskov EA; Gonzales J; Gorshkov BA; Sridhar S; Chakraborty T; Lucas R; Verin AD
    J Cell Physiol; 2010 Apr; 223(1):215-23. PubMed ID: 20054824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.
    Boardman R; Pang V; Malhi N; Lynch AP; Leach L; Benest AV; Bates DO; Machado MJC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1065-H1075. PubMed ID: 30681366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells.
    Schlegel N; Waschke J
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C453-62. PubMed ID: 19118163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
    Liang X; Wu L; Hand T; Andreasson K
    J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP.
    Birukova AA; Burdette D; Moldobaeva N; Xing J; Fu P; Birukov KG
    Microvasc Res; 2010 Mar; 79(2):128-38. PubMed ID: 19962392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKA and Epac1 regulate endothelial integrity and migration through parallel and independent pathways.
    Lorenowicz MJ; Fernandez-Borja M; Kooistra MR; Bos JL; Hordijk PL
    Eur J Cell Biol; 2008 Oct; 87(10):779-92. PubMed ID: 18635287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo.
    Murata T; Lin MI; Aritake K; Matsumoto S; Narumiya S; Ozaki H; Urade Y; Hori M; Sessa WC
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):20009-14. PubMed ID: 19060214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.
    Garg J; Feng YX; Jansen SR; Friedrich J; Lezoualc'h F; Schmidt M; Wieland T
    Oncotarget; 2017 Jul; 8(27):44732-44748. PubMed ID: 28512254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular adenosine-induced Rac1 activation in pulmonary endothelium: Molecular mechanisms and barrier-protective role.
    Kovacs-Kasa A; Kim KM; Cherian-Shaw M; Black SM; Fulton DJ; Verin AD
    J Cell Physiol; 2018 Aug; 233(8):5736-5746. PubMed ID: 29168172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mechanisms of adenosine- and ATPγS-induced microvascular endothelial barrier strengthening.
    Bátori R; Kumar S; Bordán Z; Cherian-Shaw M; Kovács-Kása A; MacDonald JA; Fulton DJR; Erdődi F; Verin AD
    J Cell Physiol; 2019 May; 234(5):5863-5879. PubMed ID: 29271489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation.
    Sarashina H; Tsubosaka Y; Omori K; Aritake K; Nakagawa T; Hori M; Hirai H; Nakamura M; Narumiya S; Urade Y; Ozaki H; Murata T
    J Immunol; 2014 Jan; 192(1):459-65. PubMed ID: 24298012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1.
    Aslam M; Gündüz D; Schuler D; Li L; Sharifpanah F; Sedding D; Piper HM; Noll T
    Cardiovasc Res; 2011 Nov; 92(2):276-86. PubMed ID: 21816966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown.
    Baumer Y; Spindler V; Werthmann RC; Bünemann M; Waschke J
    J Cell Physiol; 2009 Sep; 220(3):716-26. PubMed ID: 19472214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.
    Singleton PA; Dudek SM; Chiang ET; Garcia JG
    FASEB J; 2005 Oct; 19(12):1646-56. PubMed ID: 16195373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils.
    Mesquita-Santos FP; Bakker-Abreu I; Luna-Gomes T; Bozza PT; Diaz BL; Bandeira-Melo C
    Br J Pharmacol; 2011 Apr; 162(8):1674-85. PubMed ID: 20973774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.